New hope to stop kidney damage after hospital stay
NCT ID NCT07182422
Summary
This study is testing whether adding a medication called Kremezin (AST-120) to standard care helps people recover from acute kidney injury. Researchers want to see if the drug can lower harmful toxins in the blood, help the kidneys heal better, and prevent the injury from turning into long-term kidney disease. The trial will involve 100 adults who recently had significant kidney damage during a hospital stay.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE KIDNEY INJURY (AKI) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Chang Gung Memorial Hospital, Taoyuan, Taiwan
RECRUITINGTaoyuan District, 333, Taiwan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.